Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S18C (MRPS18C) is a nuclear-encoded protein that is a structural component of the mitochondrial small 28S ribosomal subunit. It belongs to the ribosomal protein S18P family and is crucial for protein synthesis within the mitochondrion. MRPS18C is one of three human mitochondrial S18 proteins, each distantly related to bacterial S18 proteins, and it supports the translation of mitochondrial-encoded proteins as part of the mitoribosome[1][2][6][8]. No direct evidence suggests it is a therapeutic target, nor are there known drugs targeting this protein. It is primarily a core housekeeping component in mitochondria and not usually considered a drug target in biomedical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S18C (MRPS18C).